NCT02993731 2023-11-15CanStem111PSumitomo Pharma America, Inc.Phase 3 Completed1,134 enrolled 18 charts
NCT02715804 2020-07-14A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal AdenocarcinomaHalozyme TherapeuticsPhase 3 Terminated492 enrolled 16 charts